Literature DB >> 31207067

SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells.

Sabrina Pengam1, Justine Durand1,2, Claire Usal2, Vanessa Gauttier1, Nahzli Dilek1,2, Bernard Martinet2, Véronique Daguin2, Caroline Mary1, Virginie Thepenier1, Géraldine Teppaz1, Karine Renaudin3, Gilles Blancho2,3, Bernard Vanhove1, Nicolas Poirier1.   

Abstract

Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature hematopoietic precursors known to suppress immune responses. Interaction of SIRP alpha (SIRPα), expressed by myeloid cells, with the ubiquitous receptor CD47 is an important immune checkpoint of the innate response regulating macrophages and dendritic cells functions. We previously described that MDSC expressing SIRPα accumulated after transplantation and maintained kidney allograft tolerance. However, the role of the SIRPα/CD47 axis on MDSC function remained unknown. Here, we found that blocking SIRPα or CD47 with monoclonal antibodies (mAbs) induced differentiation of MDSC into myeloid cells overexpressing MHC class II, CD86 costimulatory molecule and increased secretion of macrophage-recruiting chemokines (eg, MCP-1). Using a model of long-term kidney allograft tolerance sustained by MDSC, we observed that administration of blocking anti-SIRPα or CD47 mAbs induced graft dysfunction and rejection. Loss of tolerance came along with significant decrease of MDSC and increase in MCP-1 concentration in the periphery. Graft histological and transcriptomic analyses revealed an inflammatory (M1) macrophagic signature at rejection associated with overexpression of MCP-1 mRNA and protein in the graft. These findings indicate that the SIRPα-CD47 axis regulates the immature phenotype and chemokine secretion of MDSC and contributes to the induction and the active maintenance of peripheral acquired immune tolerance.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  CD47; SIRP alpha; basic (laboratory) research/science; chemokine; graft tolerance; immune regulation; immunobiology; immunosuppression/immune modulation; macrophage/monocyte biology; myeloid-derived suppressor cells; tolerance: mechanisms

Year:  2019        PMID: 31207067     DOI: 10.1111/ajt.15497

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  11 in total

Review 1.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

2.  Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis.

Authors:  Qinjun Shen; Li Zhao; Linyue Pan; Dandan Li; Gang Chen; Zhihong Chen; Zhilong Jiang
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

3.  Changes in phenotypic patterns of blood monocytes after kidney transplantation and during acute rejection.

Authors:  V Švachová; L Krupičková; M Novotný; M Fialová; K Mezerová; E Čečrdlová; V Lánská; A Slavčev; O Viklický; O Viklický; I Stříž
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

Review 4.  Macrophages in Organ Transplantation.

Authors:  Farideh Ordikhani; Venu Pothula; Rodrigo Sanchez-Tarjuelo; Stefan Jordan; Jordi Ochando
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

5.  Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.

Authors:  Tracy C Kuo; Amy Chen; Ons Harrabi; Jonathan T Sockolosky; Anli Zhang; Emma Sangalang; Laura V Doyle; Steven E Kauder; Danielle Fontaine; Sangeetha Bollini; Bora Han; Yang-Xin Fu; Janet Sim; Jaume Pons; Hong I Wan
Journal:  J Hematol Oncol       Date:  2020-11-30       Impact factor: 17.388

Review 6.  Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression.

Authors:  Zhuang Chen; Rui Yuan; Shengyun Hu; Weitang Yuan; Zhenqiang Sun
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

7.  SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies.

Authors:  Rima M Saliba; Samer A Srour; Uri Greenbaum; Qing Ma; Yudith Carmazzi; Michael Moller; Janet Wood; Stefan O Ciurea; Piyanuch Kongtim; Gabriela Rondon; Dan Li; Supawee Saengboon; Amin M Alousi; Katayoun Rezvani; Elizabeth J Shpall; Kai Cao; Richard E Champlin; Jun Zou
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

Review 8.  Macrophage Heterogeneity in Kidney Injury and Fibrosis.

Authors:  Yi Wen; Hong-Ru Yan; Bin Wang; Bi-Cheng Liu
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

9.  Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy.

Authors:  Huanpeng Chen; Yuying Yang; Yuqing Deng; Fengjiao Wei; Qingyu Zhao; Yongqi Liu; Zhonghua Liu; Bolan Yu; Zhaofeng Huang
Journal:  J Immunother Cancer       Date:  2022-02       Impact factor: 13.751

10.  YAP-Dependent Induction of CD47-Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia-Reperfusion Injury.

Authors:  Zenan Yuan; Linsen Ye; Xiao Feng; Tian Zhou; Yi Zhou; Shuguang Zhu; Changchang Jia; Haibo Li; Dongbo Qiu; Kun Li; Wei Liu; Yang Li; Hui Tang; Guoying Wang; Qi Zhang; Yang Yang; Guihua Chen; Hua Li
Journal:  Oxid Med Cell Longev       Date:  2021-06-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.